- $1.35bn
- $1.00bn
- 44
- 25
- 48
- 33
Annual balance sheet for Disc Medicine, fiscal year end - December 31st, millions except per share.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | |
| Standards: | — | USG | USG | USG | USG |
| Status: | fx Preliminary | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | — | 1.21 | 137 | 195 | 360 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | — | 1.34 | 140 | 198 | 366 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | — | — | 0 | 1.6 | 2.1 |
| Other Long Term Assets | |||||
| Total Assets | — | 122 | 140 | 200 | 368 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | — | 0.598 | 14.8 | 22.6 | 21.4 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | — | 4.82 | 15.6 | 23.6 | 22.9 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | — | 117 | 125 | 177 | 345 |
| Total Liabilities & Shareholders' Equity | — | 122 | 140 | 200 | 368 |
| Total Common Shares Outstanding |